SESSION 2: LAF and the Hormone Connection (January 15 � January 31, 2003)

SESSION 3: Hypoglycemia (February 14 � February 28, 2003)

SESSION 4: GABA and Afib (March 5 � March 31, 2003)

SESSION 5: GABA and Glutamate � Part 1 (March 31 � April 11, 2003)

SESSION 6: GABA and Glutamate � Part 2 (April 12 � May 12, 2003)

SESSION 7: LAF and Antidepressants (May 13 � May 31, 2003)

SESSION 8: Ablation (May 23 � June 30, 2003)

SESSION 9: Ablation and Radiation Exposure (July 1 � July 31, 2003)

SESSION 10: LAF and Red Wine (July 28 � August 31, 2003)

SESSION 11: Hydration and Aldosterone (August 1 � August 31, 2003)

SESSION 12: Ativan (lorazepam) and LAF(August 21 � September 15, 2003)

SESSION 13: Managing Afib � Are We Getting Close?(September 4 � September 31, 2003)

SESSION 14: Calcium Magnesium Imbalance: Are There Consequences?(September 25 � October 15, 2003)

SESSION 14 A: Magnesium and Potassium in LAF by Patrick Chambers, MD

SESSION 14 B: Magnesium Abstracts from IHN Database

SESSION 15: Copper: The Missing Link?(October 14 � November 4, 2003)

SESSION 16: Molybdenum(October 20 � November 4, 2003)

SESSION 17: Methionine (Sulfur) � Acetylcholine � Glutamate (November 1 � November 30, 2003)

SESSION 18: Mechanism of LAF (November 12 � November 30, 2003)

SESSION 19: Candida and LAF (November 24 � December 15, 2003)

SESSION 20: Methylation (December 21 - January 8, 2004)

SESSION 21: Ablation Sequels (January 8 - January 24, 2004)

SESSION 22: LAF and Taurine (January 17 - January 24, 2004)

SESSION 23: Magnesium, NMDA receptors and LAF (January 25 - February 9, 2004)

SESSION 24: Cardiac Fibrotic Remodeling (February 9 - February 20, 2004)

SESSION 25: Mitral Valve Prolapse, Magnesium Deficiency and LAF (February 20 - March 6, 2004)

SESSION 26: The Aldosterone Connection - Breakthrough? (March 3 - March 31, 2004)

SESSION 27: Subclinical hypothyroidism and LAF (March 25 - April 15, 2004)

SESSION 28: LAF, GERD and Diaphragm Displacement (April 12 - May 15, 2004)

SESSION 29: Fear, Anxiety and Afib (June 21 - June 30, 2004)

SESSION 30: LAF and the Enteric Nervous System (June 30 - August 15, 2004)

SESSION 31: LAF and ACE Inhibitors (August 22 - September 15, 2004)

SESSION 32: Afib-friendly Recipes (September 14 - September 30, 2004)

SESSION 33: Baroreceptor Sensitivity and Aldosterone (November 4 - November 21, 2004)

SESSION 34: LAF and Microwave Radiation (December 4 - December 31, 2004)

SESSION 35: P Cells and Free Radicals (January 7 - January 29, 2005)

SESSION 36: Right Side vs Left Side (January 17 - January 29, 2005)

SESSION 37: Diurnal Rhythm of Potassium (January 29 - March 5, 2005)

SESSION 38: The PAC-Tamer: The Ultimate K-supplement? (March 5 - March 31, 2005)

SESSION 39: Nattokinase - Interim Survey (March 10 - April 25, 2005)

SESSION 40: Nattokinase: Update and Summary (April 27 - May 15, 2005)

SESSION 41: Vitamin D and LAF (May 18 - May 31, 2005)

SESSION 42: H. pylori and Atrial Fibrillation (June 1 - June 30, 2005)

SESSION 43: LAF and the Hormone Connection II (July 1 - July 21, 2005)

SESSION 44: Predicting LAF in Children (September 22, 2005 - October 21, 2005)

SESSION 45: Ectopy and LAF (November 1, 2005 - December 15, 2005)

SESSION 46: LAF and Undesirable Effects of Supplements (December 18, 2005 - January 15, 2006)

SESSION 47: Post-ablation problems (January 12, 2006 - January 29, 2006)

SESSION 48: LAF and Insulin (January 29, 2006 - February 25, 2006)

SESSION 49: Taurine WITH l-arginine for arrhythmias (March 2, 2006 - March 21, 2006)

SESSION 50: Pre and Post Ablation PACs (April 16, 2006 - May 15, 2006)

SESSION 51: MVP, ANP, P cells, hydration and LAF (May 17, 2006 - June 15, 2006)

SESSION 52: Monitoring Devices and Methods (June 20, 2006 - July 21, 2006) NOTE: This file is large and may be slow to download

SESSION 52a: Monitoring Devices and Methods II (December 18, 2007 - January 30, 2008) NOTE: This file is large and may be slow to download

SESSION 53: Magnesium Supplementation - Friend or Foe? (July 21, 2006 - August 15, 2006)

SESSION 54: Examining Success of Paleo Diet in Afibbers (September 2, 2006 - September 30, 2006)

SESSION 55: Is LAF Physiologic or Pathologic? (December 12, 2006 - February 6, 2007)

SESSION 56: Post-procedure PACs (February 13, 2007 - March 6, 2007)

SESSION 57: LAF: The Case for Entrapment (March 6, 2007 - March 30, 2007)

SESSION 58: LAF and Niacin (March 21, 2007 - May 11, 2007)

SESSION 59: Dysautonomia and LAF (May 22, 2007 - June 15, 2007)

SESSION 60: Left atrial flutter and other post-procedure arrhythmias (July 14 - August 13, 2007)

SESSION 61: Protocols for reducing/eliminating afib (November 5 -December 15, 2007)

SESSION 62: LAF and Migraine (March 3 -March 31, 2008)

SESSION 63: No More Heartburn by Jackie Burgess (March 2008)

SESSION 64: Exercise and Afib (May 21 - June 15, 2008)

SESSION 65: H. pylori eradication by natural means (July 21 - August 15, 2009)

SESSION 66: Possible Role for Acid-Base Balance (August 13 - August 31, 2009)

SESSION 67: Future of Catheter Ablations (December 26, 2009 - January 31, 2010)

SESSION 68: Seasonal Variations in Afib Frequency (February 1 - March 15, 2010)

SESSION 69: Probiotics and Wheat Sensitivity (February 1 - March 15, 2010)

SESSION 70: Computer-assisted management of atrial fibrillation (March 23 - April 30, 2010)

SESSION 71: European Guidelines for the Management of Atrial Fibrillation (November 2 - November 24, 2010)

SESSION 72: Potassium/Sodium Ratio in Atrial Fibrillation (February 7 - June 11, 2011)

SESSION 73: LAF and Ketosis (August 1 - November 10, 2011)

SESSION 74: Potassium Level Monitoring with Cardymeter (June 4, 2011 - October 15, 2012)

SESSION 75: LAF and Cardiac Fibrosis (August 17 - December 2, 2012)